-
Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approache
Author: Lu, Zhenhuan; Li, Xiaowen; Liang, Zhiping; Zhang, Xiaocong; Tan, Yiyan; Kuang, Yinglan; Li, Kang; Zhu, Xiaofeng
Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S566928
-
Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Repor
Author: Xu, Ruoxiang; Zhang, Mingrui; Zeng, Zhiming; Wei, Yongguang; Liao, Xiwen; Yang, Chengkun; Peng, Tao; Su, Hao
Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S578577
-
Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Revie
Author: Xie, Zhuohua; Deng, Yanting; Zhang, Xinru; Chen, Jieyi; Deng, Jiasheng; Fang, Yibin; Ye, Xiaoxue; Zhou, Zhipin
Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S555701
-
Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Stud
Author: Han, Ruixue; Yu, Xin
Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S566952
-
Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinom
Author: Li, Shouying; Zhang, Chunfang; Lv, Shengxiang; Zhang, Zhimei; Xu, Dazhou; Xu, Tonglei
Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2026; Vol. 19, Issue , pp. -. DOI: 10.2147/PGPM.S562602
-
Associations Between FTO Polymorphisms and Neuroblastoma Risk in Chinese Childre
Author: Liu, Peiqi; Li, Yue; Li, Yong; Li, Li; Cheng, Jiwen; Li, Suhong; Zhang, Jiao; Zhou, Haixia; Huo, Yunlong; Yang, Zhonghua; He, Jing; Zhang, Ran
Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2025; Vol. 18, Issue , pp. 143-151. DOI: 10.2147/PGPM.S488314
-
Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencin
Author: Chen, Qianwen; Zhang, Wenjuan; Zha, Lingfeng
Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2025; Vol. 18, Issue , pp. 153-162. DOI: 10.2147/PGPM.S514145
-
Novel SLC16A2 Frameshift Mutation as a Cause of Allan-Herndon-Dudley Syndrome and its Implications for Carrier Screenin
Author: Lin, Peng; Liu, Huituan; Lou, Jiwu; Lyu, Guizhen; Li, Yanwei; He, Peiqing; Fu, Youqing; Zhang, Ronghua; Zhang, Yuqiong; Yan, Tizhen
Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2025; Vol. 18, Issue , pp. 85-94. DOI: 10.2147/PGPM.S492647
